116 related articles for article (PubMed ID: 36873672)
1. Relationship of thyroid function with genetic subtypes and treatment with growth hormone in Prader-Willi syndrome.
Schmok T; Surampalli A; Khare M; Zandihaghighi S; Baghbaninogourani R; Patolia B; Gold JA; Naidu A; Cassidy SB; Kimonis VE
Am J Med Genet A; 2024 Jun; ():e63724. PubMed ID: 38837660
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin's Regulation of Thermogenesis May Be the Link to Prader-Willi Syndrome.
Camerino C
Curr Issues Mol Biol; 2023 Jun; 45(6):4923-4935. PubMed ID: 37367062
[TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader-Willi syndrome.
Kweh FA; Sulsona CR; Miller JL; Driscoll DJ
Obes Sci Pract; 2023 Aug; 9(4):383-394. PubMed ID: 37546289
[TBL] [Abstract][Full Text] [Related]
4. Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.
Miller JL; Gevers E; Bridges N; Yanovski JA; Salehi P; Obrynba KS; Felner EI; Bird LM; Shoemaker AH; Angulo M; Butler MG; Stevenson D; Abuzzahab J; Barrett T; Lah M; Littlejohn E; Mathew V; Cowen NM; Bhatnagar A;
J Clin Endocrinol Metab; 2023 Jun; 108(7):1676-1685. PubMed ID: 36639249
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in Prader-Willi Syndrome.
Mendiola AJP; LaSalle JM
Front Genet; 2021; 12():624581. PubMed ID: 33659026
[TBL] [Abstract][Full Text] [Related]
6. The Hyperphagia Questionnaire: Insights From a Multicentric Validation Study in Individuals With Prader Willi Syndrome.
Licenziati MR; Bacchini D; Crinò A; Grugni G; Fintini D; Osimani S; Ragusa L; Sacco M; Iughetti L; De Sanctis L; Franzese A; Wasniewska MG; Faienza MF; Delvecchio M; Esposito C; Valerio G
Front Pediatr; 2022; 10():829486. PubMed ID: 35237541
[TBL] [Abstract][Full Text] [Related]
7. The treatment of obesity in children and adolescents: consensus position statement of the Italian society of pediatric endocrinology and diabetology, Italian Society of Pediatrics and Italian Society of Pediatric Surgery.
Maffeis C; Olivieri F; Valerio G; Verduci E; Licenziati MR; Calcaterra V; Pelizzo G; Salerno M; Staiano A; Bernasconi S; Buganza R; Crinò A; Corciulo N; Corica D; Destro F; Di Bonito P; Di Pietro M; Di Sessa A; deSanctis L; Faienza MF; Filannino G; Fintini D; Fornari E; Franceschi R; Franco F; Franzese A; Giusti LF; Grugni G; Iafusco D; Iughetti L; Lera R; Limauro R; Maguolo A; Mancioppi V; Manco M; Del Giudice EM; Morandi A; Moro B; Mozzillo E; Rabbone I; Peverelli P; Predieri B; Purromuto S; Stagi S; Street ME; Tanas R; Tornese G; Umano GR; Wasniewska M
Ital J Pediatr; 2023 Jun; 49(1):69. PubMed ID: 37291604
[TBL] [Abstract][Full Text] [Related]
8. Prader-Willi Syndrome and Weight Gain Control: From Prevention to Surgery-A Narrative Review.
Calcaterra V; Magenes VC; Destro F; Baldassarre P; Silvestro GS; Tricella C; Visioli A; Verduci E; Pelizzo G; Zuccotti G
Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980122
[TBL] [Abstract][Full Text] [Related]
9. The Arduous Path to Drug Approval for the Management of Prader-Willi Syndrome: A Historical Perspective and Call to Action.
Singh D; Miller JL; Wassman ER; Butler MG; Foley Shenk A; Converse M; Picone M
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511333
[TBL] [Abstract][Full Text] [Related]
10. Using
Sun JR; Yang LZ; Dai YL; Wu H; Li S; Xu YF; Huang Y; Wu H; Shen Z; Zou C; Chen LL
RNA Biol; 2023 Jan; 20(1):419-430. PubMed ID: 37405372
[TBL] [Abstract][Full Text] [Related]
11. The relationship between endogenous oxytocin and vasopressin levels and the Prader-Willi syndrome behaviour phenotype.
Rice LJ; Agu J; Carter CS; Harris JC; Nazarloo HP; Naanai H; Einfeld SL
Front Endocrinol (Lausanne); 2023; 14():1183525. PubMed ID: 37313445
[TBL] [Abstract][Full Text] [Related]
12. Current Treatments for Patients with Genetic Obesity.
Faccioli N; Poitou C; Clément K; Dubern B
J Clin Res Pediatr Endocrinol; 2023 May; 15(2):108-119. PubMed ID: 37191347
[TBL] [Abstract][Full Text] [Related]
13. Prader-Willi Syndrome and Chromosome 15q11.2 BP1-BP2 Region: A Review.
Butler MG
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901699
[TBL] [Abstract][Full Text] [Related]
14. The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress.
Jászberényi M; Thurzó B; Bagosi Z; Vécsei L; Tanaka M
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398050
[TBL] [Abstract][Full Text] [Related]
15. Hyperphagia in Prader-Willi syndrome with obesity: From development to pharmacological treatment.
Rahman QFA; Jufri NF; Hamid A
Intractable Rare Dis Res; 2023 Feb; 12(1):5-12. PubMed ID: 36873672
[TBL] [Abstract][Full Text] [Related]
16. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
[TBL] [Abstract][Full Text] [Related]
17. Clinical Trials in Prader-Willi Syndrome: A Review.
Mahmoud R; Kimonis V; Butler MG
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
[TBL] [Abstract][Full Text] [Related]
18. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
Goldstone AP; Holland AJ; Butler JV; Whittington JE
Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
[TBL] [Abstract][Full Text] [Related]
19. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
Angulo MA; Butler MG; Cataletto ME
J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
